References
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68:394–424.
- IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, Schistosomes, Liver Flukes and Helicobacter pylori. Vol 61 of IARC monographs on the evaluation of carcinogenic risks to humans. International Agency for Research on Cancer, Lyon; 1994.
- Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014; 23:700–13.
- Choi YJ, Kim N. Gastric cancer and family history. Korean J Intern Med. 2016; 31:1042–53.
- Hanley AJ, Choi BC, Holowaty EJ. Cancer mortality among Chinese migrants: a review. Int J Epidemiol. 1995; 24:255–65.
- Oliveira C, Pinheiro H, Figueiredo J, Seruca R, Carneiro F. Familial gastric cancer: genetic susceptibility, pathology, and implications for management. Lancet Oncol. 2015; 16:e60–70.
- Bhayal AC, Krishnaveni D, RangaRao KP, Bogadi V, Suman C, Jyothy A, et al. Role of tumor necrosis factor-α −308 G/A promoter polymorphism in gastric cancer. Saudi J Gastroenterol. 2013; 19:182–6.
- Jiang X, Naikoo NA, Gao S. Meta-analysis of tumor necrosis factor-α −308 G>A polymorphism in gastric cancer. Asian Biomed (Research Review News). 2020; 14:91–6.
- de Vries AC, Kuipers EJ. Epidemiology of premalignant gastric lesions: implications for the development of screening and surveillance strategies. Helicobacter. 2007; 12(Suppl 2):22–31.